Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)
This is the 2010 version of HCPCS G9126 - please refer to the 2016 HCPCS code set for the latest version.
Added on Sunday, January 01, 2006
Status changed on Monday, January 01, 2007 to: No maintenance for this code